BRÈVE publiée le 24/03/2026 à 14:35, il y a 3 mois 29 jours Sibanye Gold Adjusts Convertible Bonds Conversion Price Convertible Bonds Dividend Conversion Price 2028 Bonds Sibanye Gold
BRÈVE publiée le 24/03/2026 à 14:35, il y a 3 mois 29 jours Sibanye Gold ajuste le prix de conversion de ses obligations convertibles Obligations Convertibles Dividende Prix De Conversion Obligations 2028 Sibanye Gold
COMMUNIQUÉ DE PRESSE publié le 24/03/2026 à 14:30, il y a 3 mois 29 jours EQS-Adhoc: Sibanye Gold Limited: USD 500,000,000 4.250 per cent. Guaranteed Unsecured Convertible Bonds due 2028 Sibanye Gold Limited announces adjustment of Conversion Price for USD 500,000,000 4.250% Guaranteed Unsecured Convertible Bonds due 2028 Convertible Bonds Dividend Conversion Price Adjustment Sibanye Gold Limited
Publié le 22/07/2026 à 18:19, il y a 11 heures 9 minutes Covivio place avec succès 500 M€ d’obligations vertes à 7 ans
Publié le 22/07/2026 à 18:19, il y a 11 heures 9 minutes Covivio successfully places €500 million of 7-year European Green Bonds
Publié le 22/07/2026 à 17:45, il y a 11 heures 43 minutes Groupe CRIT : 2026 first half revenue: €1.67 billion (+2.3% on an organic basis).
Publié le 22/07/2026 à 17:45, il y a 11 heures 43 minutes Groupe CRIT : Chiffre d’affaires du 1er semestre 2026 : 1,67 Md€ (+2,3% en organique).
Publié le 22/07/2026 à 17:40, il y a 11 heures 48 minutes Report on share repurchases from 15 to 21 July 2026
Publié le 22/07/2026 à 15:00, il y a 14 heures 28 minutes Karbon-X Secures Technical Advisory Engagement for Nature-Based Carbon Project in Libya
Publié le 22/07/2026 à 15:00, il y a 14 heures 28 minutes Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
Publié le 22/07/2026 à 14:35, il y a 14 heures 53 minutes Wi2Wi Reports Significant Manufacturing Yield Improvement in Q2 2026
Publié le 22/07/2026 à 14:30, il y a 14 heures 58 minutes As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola
Publié le 23/07/2026 à 02:05, il y a 3 heures 23 minutes JINRO Unveils First Global Campaign "My Favorite JINRO" with V of BTS
Publié le 22/07/2026 à 23:58, il y a 5 heures 30 minutes EQS-Adhoc: Deutsche Rohstoff AG: Increase in 2026 Guidance: EBITDA of approximately EUR 365 million expected
Publié le 22/07/2026 à 22:20, il y a 7 heures 8 minutes Quantinuum Appoints Chief Legal Officer and Chief People Officer
Publié le 22/07/2026 à 21:01, il y a 8 heures 27 minutes EQS-Adhoc: Correction of a release from 22/07/2026, 20:08 CET/CEST - FUCHS SE: Preliminary results for the first half of the year ahead of expectations and increase in the EBIT forecast for 2026
